Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

CD34 + CD19 - CD22 + B-cell progenitors might underlie phenotypic escape in patients treated with CD19-directed therapies

Blood blood.2021014840.

DOI: https://doi.org/10.1182/blood.2021014840

Published: 2022

Includes: Supplemental data

Journal Articles

Results from a Pilot Study of ARI0002h, an Academic BCMA-Directed CAR-T Cell Therapy with Fractionated Initial Infusion and Booster Dose in Patients with Relapsed and/or Refractory Multiple Myeloma

Blood (2021) 138 (Supplement 1): 2837.

DOI: https://doi.org/10.1182/blood-2021-147188

Published: 2021

Journal Articles

CAR Density Influences Antitumoral Efficacy of BCMA CAR-T Cells and Correlates with Clinical Outcome

Blood (2021) 138 (Supplement 1): 735.

DOI: https://doi.org/10.1182/blood-2021-148578

Published: 2021

Journal Articles

Correlative Biological Studies Related to the Response, Peak and Persistence of ARI0002h, an Academic BCMA-Directed CAR-T Cell, with Fractionated Initial Infusion and Booster Dose for Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

Blood (2021) 138 (Supplement 1): 552.

DOI: https://doi.org/10.1182/blood-2021-148281

Published: 2021

Journal Articles

Design and in Vitro Evaluation of a CAR-T Prototype (ARI-0003) Targeting CD123 for Acute Myeloid Leukemia

Alex Bataller Torralba, Néstor Tirado, Diego Sánchez-Martínez, Talía Velasco-Hernández, Aina Oliver-Caldés, Sandra Castaño-Díez, Francesca Guijarro, Marina Diaz-Beyá, Manel Juan, Pablo Engel, Clara Bueno, Pablo Menendez, Álvaro Urbano-Ispizua, Jordi Esteve

Blood (2021) 138 (Supplement 1): 4799.

DOI: https://doi.org/10.1182/blood-2021-153356

Published: 2021

Journal Articles

Targeting IRAK4 Disrupts Inflammatory Pathways and Delays Tumor Development in Chronic Lymphocytic Leukemia

Neus Giménez Carabaza, B.Pharm, Rosich Laia, PhD, Schulz Ralph, MS, Higashi Morihiro, MD, Marta Aymerich, Neus Villamor, PhD, Julio Delgado, MD, Manel Juan, MD, Monica Lopez-Guerra, PhD, Elias Campo, Martina Seiffert, PhD, Dolors Colomer, PhD

Blood (2018) 132 (Supplement 1): 2650.

DOI: https://doi.org/10.1182/blood-2018-99-115999

Published: 2018

Journal Articles

Long-Term Survivors after Stem Cell Transplantation in Multiple Myeloma: Bone Marrow Minimal Residual Disease, PET/CT and Immunological Status

Carlos Fernández de Larrea, Xavier Calvo, Natalia Tovar, Ester Lozano, Xavier Setoain, Manel Juan, Tania Díaz, Laura Rosiñol, Montserrat Elena, Mª Teresa Cibeira, Ignacio Isola, Maria Rozman, Juan I. Aróstegui, Jordi Yagüe, Joan Bladé, MD

Blood (2015) 126 (23): 4192.

DOI: https://doi.org/10.1182/blood.V126.23.4192.4192

Published: 2015

Journal Articles

Mutations in TLR/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome

Blood (2014) 123 (24): 3790–3796.

DOI: https://doi.org/10.1182/blood-2013-12-543306

Published: 2014

Includes: Supplemental data

Journal Articles

Immune Status In Patients with Chronic Lymphocytic Leukemia and Sustained Complete Remission: A Multiparametric Analysis

Kate E Hodgson, MD, Gerardo Ferrer, Carmen Martinez, MD, Manel Juan, Tycho Baumann, MD, Montserrat Rovira, MD, Marta Aymerich, Laura Carretero, Francesc Bosch, MD, Alvaro Urbano, MD, Emili Montserrat, MD, Carol Moreno, MD, PhD

Blood (2010) 116 (21): 1389.

DOI: https://doi.org/10.1182/blood.V116.21.1389.1389

Published: 2010

Journal Articles

Long-Term Immune Reconstitution Following Stem Cell Transplantation in Chronic Lymphocytic Leukemia.

Kate E Hodgson, Gerardo Ferrer, Carmen Martinez, Manel Juan, Montserrat Rovira, Marta Aymerich, Laura Carretero, Francesc Fernandez, Enric Carreras, Emili Montserrat, Carol Moreno

Blood (2009) 114 (22): 4649.

DOI: https://doi.org/10.1182/blood.V114.22.4649.4649

Published: 2009

Journal Articles

Mapping of Helper Epitopes to HPA-1a in Neonatal Alloimmune Thrombocytopenia with T-Cell Clones

Rachel Rayment, MBChB, DPhil, Nick Willcox, MD, PhD, David Roberts, MD, PhD, Wendy J Pickford, BSc, PhD, Rosa Faner-Canet, Manel Juan, MD, Robert N Barker, BSc, PhD, Stanislaw J Urbaniak, MBChB, PhD, FRCP, FRCPath

Blood (2008) 112 (11): 3040.

DOI: https://doi.org/10.1182/blood.V112.11.3040.3040

Published: 2008

Journal Articles

Common variants in NLRP2 and NLRP3 genes are strong prognostic factors for the outcome of HLA-identical sibling allogeneic stem cell transplantation

Miquel Granell, Álvaro Urbano-Ispizua, Aina Pons, Juan Ignacio Aróstegui, Bernat Gel, Alfons Navarro, Sonia Jansa, Rosa Artells, Anna Gaya, Carme Talarn, Francesc Fernández-Avilés, Carmen Martínez, Montserrat Rovira, Enric Carreras, Ciril Rozman, Manel Juan, Jordi Yagüe, Emili Montserrat, Mariano Monzó

Blood (2008) 112 (10): 4337–4342.

DOI: https://doi.org/10.1182/blood-2007-12-129247

Published: 2008

Includes: Supplemental data

Journal Articles

Fibronectin Upregulates Gelatinase B (MMP-9) and Induces Coordinated Expression of Gelatinase A (MMP-2) and Its Activator MT1-MMP (MMP-14) by Human T Lymphocyte Cell Lines. A Process Repressed Through RAS/MAP Kinase Signaling Pathways

Jordi Esparza, Carme Vilardell, Javier Calvo, Manel Juan, Jordi Vives, Alvaro Urbano-Márquez, Jordi Yagüe, Maria C. Cid

Blood (1999) 94 (8): 2754–2766.

DOI: https://doi.org/10.1182/blood.V94.8.2754.420k09_2754_2766

Published: 1999

NARROW

CD34 + CD19 - CD22 + B-cell progenitors might underlie phenotypic escape in patients treated with CD19-directed therapies

Results from a Pilot Study of ARI0002h, an Academic BCMA-Directed CAR-T Cell Therapy with Fractionated Initial Infusion and Booster Dose in Patients with Relapsed and/or Refractory Multiple Myeloma

CAR Density Influences Antitumoral Efficacy of BCMA CAR-T Cells and Correlates with Clinical Outcome

Correlative Biological Studies Related to the Response, Peak and Persistence of ARI0002h, an Academic BCMA-Directed CAR-T Cell, with Fractionated Initial Infusion and Booster Dose for Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

Design and in Vitro Evaluation of a CAR-T Prototype (ARI-0003) Targeting CD123 for Acute Myeloid Leukemia

Targeting IRAK4 Disrupts Inflammatory Pathways and Delays Tumor Development in Chronic Lymphocytic Leukemia

Long-Term Survivors after Stem Cell Transplantation in Multiple Myeloma: Bone Marrow Minimal Residual Disease, PET/CT and Immunological Status

Mutations in TLR/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome

Immune Status In Patients with Chronic Lymphocytic Leukemia and Sustained Complete Remission: A Multiparametric Analysis

Long-Term Immune Reconstitution Following Stem Cell Transplantation in Chronic Lymphocytic Leukemia.

Mapping of Helper Epitopes to HPA-1a in Neonatal Alloimmune Thrombocytopenia with T-Cell Clones

Common variants in NLRP2 and NLRP3 genes are strong prognostic factors for the outcome of HLA-identical sibling allogeneic stem cell transplantation

Fibronectin Upregulates Gelatinase B (MMP-9) and Induces Coordinated Expression of Gelatinase A (MMP-2) and Its Activator MT1-MMP (MMP-14) by Human T Lymphocyte Cell Lines. A Process Repressed Through RAS/MAP Kinase Signaling Pathways

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only